Excess healthcare spending associated with fractures among adults with cerebral palsy. Issue 3 (July 2022)

• Record Type: Journal Article
• Authors: Whitney, Daniel G.; Caird, Michelle S.; Jepsen, Karl J.; Hurvitz, Edward A.; Hirth, Richard A.
• Is Part Of: Disability and health journal. Volume 15:Issue 3(2022)
• Publication Date: 2022-07
• Subjects: Cerebral palsy -- Fracture -- Healthcare costs -- Economic -- Clinical epidemiology; People with disabilities -- Health and hygiene -- Periodicals; Health education -- Periodicals; Disabled Persons -- Periodicals; Health Education -- Periodicals; Electronic journals; 362.4
• DOI: 10.1016/j.dhjo.2022.101315
• Languages: English
• ISSNs: 1936-6574

Abstract

Abstract: Background: Fractures represent a triple threat to adults with cerebral palsy (CP): common, accumulate early in adulthood, and are consequential to health. An economic evaluation of fractures in CP is needed to highlight priorities for allocating resources to clinical and public health programs aimed at preventing fractures and their disease sequela. Objective: To identify short-term healthcare costs associated with fractures among adults with CP. Methods: A retrospective cohort study was performed using Optum's de-identified Clinformatics® Data Mart Database from 01/01/2011-12/31/2017. The primary cohort included adults ≥ 18 years old with CP with an incident fracture (CP+Fx), and cost estimates were compared with: CP without fractures (CPw/oFx) and without CP+Fx (w/oCP+Fx). A difference-in-difference (DiD) analysis compared the change in pharmacy and medical costs between cohorts from the one-year baseline period through the one-year post-index period in three-month quarters. Results: CP+Fx (n = 855) had higher mean costs in the baseline and follow-up periods compared with CPw/oFx (n = 5667) and w/oCP+Fx (n = 588, 042). The first post-index quarter DiD estimate suggests that CP+Fx accumulated an excess $6462 (95%CI = $3810-$9021) compared with w/oCP+Fx and $17, 197 (95%CI = $14, 418-$19, 833) compared with CPw/oFx. The CP+Fx cohort had higher DiD estimates in the other follow-up quarters, but they were not statistically significant compared with CPw/oFx. When stratified by fracture site, vertebral column fractures for CP+Fx vs. w/oCP+Fx accumulated an excess $25, 226 (95%CI = $12, 639-$37, 417). Conclusions: Fractures, especially of the vertebral column, were associated with high healthcare costs among adults with CP. Studies are needed to identify cost-effective opportunities to utilize available resources to prevent fractures and their costly sequela for CP.